Geriatric Medicine Doctors in Pasadena, CA Accepting Medicare

6 Geriatric Medicine doctors found. Showing 1 - 6

Norman T Chien, MD Internal Medicine - Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 625 S Fair Oaks Ave, Suite 245, Pasadena, CA 91105 Phone: 626-229-9865    Fax: 626-229-9867

Dr. Arbis Rojas, MD Internal Medicine - Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 950 S Arroyo Pkwy Fl 3, Pasadena, CA 91105 Phone: 626-584-1919    Fax: 626-228-0695

Steven P Doan, M.D. Internal Medicine - Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 625 S Fair Oaks Ave Ste 245, Pasadena, CA 91105 Phone: 626-229-9865    Fax: 626-229-9867

Dr. Tishangi Kumar Agrawal, MD Internal Medicine - Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 625 S Fair Oaks Ave Ste 215, Pasadena, CA 91105 Phone: 626-793-4139    Fax: 626-793-4324

Dr. Jennifer Li, MD Internal Medicine - Geriatric Medicine Medicare: Medicare Enrolled Practice Location: 393 E Walnut St, Pasadena, CA 91188 Phone: 877-608-0044

Stephen Douglas Henry, M.D. Internal Medicine - Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 2319 E Washington Blvd, Suite 2, Pasadena, CA 91104 Phone: 626-797-8800    Fax: 626-797-8575

News Archive

Missing genes may help explain why plague bacteria are so deadly

What makes the germ that causes plague so fearsomely lethal, while a close relative only produces digestive disorders and is rarely fatal?

$15 million sanctioned for replacement of school gas heaters not enough say organizations

The State Government of NSW has decided upon a $15 million replacement of nearly 100 school gas heaters especially targeting cold climate areas of NSW. The New South Wales Teachers Federation said in a statement that they will be urging the government to expand the programme to other areas replacing the unflued gas heaters in schools.

Study may help optimize materials used in implants, enhance their safety

Using highly complex analytical techniques, a group of researchers from Charité - Universitätsmedizin Berlin were able to observe in detail how different metals are released from joint implants and accumulate in the surrounding bone tissue.

Advaxis reports 3-year survival data from its ADXS11-001 Phase I trial for cervical cancer

The Phase I trial of ADXS11-001, the lead vaccine candidate of Advaxis, Inc., the company that pioneered the live, attenuated Listeria monocytogenes (Lm) vaccine, has shown thirty-six (36) month survival in two (2) of the thirteen (13) evaluable patients treated with Advaxis' therapeutic cancer vaccine, indicating the possibility of persistent immune protection, from only a two (2) dose initial regimen.

Read more Medical News

› Verified 9 days ago